123 related articles for article (PubMed ID: 19010837)
1. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
2. VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis.
Lin QY; Zhang YL; Bai J; Liu JQ; Li HH
Clin Transl Med; 2021 Mar; 11(3):e374. PubMed ID: 33783987
[TBL] [Abstract][Full Text] [Related]
3. Formation of the glomerular microvasculature is regulated by VEGFR-3.
Donnan MD; Deb DK; Onay T; Scott RP; Ni E; Zhou Y; Quaggin SE
Am J Physiol Renal Physiol; 2023 Jan; 324(1):F91-F105. PubMed ID: 36395385
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.
Persaud K; Tille JC; Liu M; Zhu Z; Jimenez X; Pereira DS; Miao HQ; Brennan LA; Witte L; Pepper MS; Pytowski B
J Cell Sci; 2004 Jun; 117(Pt 13):2745-56. PubMed ID: 15150322
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
Molhoek KR; Griesemann H; Shu J; Gershenwald JE; Brautigan DL; Slingluff CL
Cancer Res; 2008 Jun; 68(11):4392-7. PubMed ID: 18519701
[TBL] [Abstract][Full Text] [Related]
6. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-C and its receptor-3 signaling in tumorigenesis.
Vimalraj S; Hariprabu KNG; Rahaman M; Govindasami P; Perumal K; Sekaran S; Ganapathy D
3 Biotech; 2023 Oct; 13(10):326. PubMed ID: 37663750
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-C modulates cortical NMDA receptor activity in cortical lesions of young patients and rat model with focal cortical dysplasia.
Shen KF; Duan QT; Duan W; Xu SL; An N; Ke YY; Wang LT; Liu SY; Yang H; Zhang CQ
Brain Pathol; 2022 Sep; 32(5):e13065. PubMed ID: 35259773
[TBL] [Abstract][Full Text] [Related]
9. Targeting Synovial Lymphatic Function as a Novel Therapeutic Intervention for Age-Related Osteoarthritis in Mice.
Lin X; Bell RD; Catheline SE; Takano T; McDavid A; Jonason JH; Schwarz EM; Xing L
Arthritis Rheumatol; 2023 Jun; 75(6):923-936. PubMed ID: 36625730
[TBL] [Abstract][Full Text] [Related]
10. Local Adenoviral Delivery of Vascular Endothelial Growth Factor C Induces Lymphangiogenesis in the Conjunctiva in Rabbits.
Rasic D; Wirenfeldt M; Askou AL; Corydon TJ; Telinius N
Ophthalmic Res; 2023; 66(1):1128-1138. PubMed ID: 37997780
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma.
Nascimento C; Gameiro A; Ferreira J; Correia J; Ferreira F
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401382
[TBL] [Abstract][Full Text] [Related]
12. Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression.
Di Fabio F; Alvarado C; Majdan A; Gologan A; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
J Gastrointest Surg; 2007 Nov; 11(11):1521-8. PubMed ID: 17703341
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Newly Diagnosed Paediatric Acute Lymphoblastic Leukemia.
Meena R; Nangia A; Sharma S; Chandra J
Indian J Hematol Blood Transfus; 2021 Oct; 37(4):586-592. PubMed ID: 34744342
[TBL] [Abstract][Full Text] [Related]
14. Expression and association of vascular endothelial growth factor, vascular endothelial growth factor receptor, and phosphorylated signal transducer and activator of transcription factor 3 in malignant gliomas.
Edura P; Vokuda R; Ramamoorthi S; Srinivas BH; Verma SK; Sasidharan G
J Neurosci Rural Pract; 2023; 14(4):723-728. PubMed ID: 38059258
[TBL] [Abstract][Full Text] [Related]
15. Effects of Hyperglycemia on Angiogenesis in Human Placental Endothelial Cells.
Yanik T; Katirci E; Simsek M; Korgun ET; Kipmen-Korgun D
Z Geburtshilfe Neonatol; 2024 May; ():. PubMed ID: 38740370
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney.
Li J; Li XL; Li CQ
Am J Med Sci; 2023 Dec; 366(6):404-412. PubMed ID: 37699444
[TBL] [Abstract][Full Text] [Related]
17. Correction: Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.
Persaud K; Tille JC; Liu M; Zhu Z; Jimenez X; Pereira DS; Miao HQ; Brennan LA; Witte L; Pepper MS; Pytowski B
J Cell Sci; 2023 Sep; 136(17):. PubMed ID: 37675777
[No Abstract] [Full Text] [Related]
18. VEGFC Gene Expression Is Associated with Tumor Progression and Disease-Free Survival in Cutaneous Squamous Cell Carcinoma.
García-Pérez O; Melgar-Vilaplana L; Sifaoui I; Śmietańska A; Córdoba-Lanús E; Fernández-de-Misa R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203550
[TBL] [Abstract][Full Text] [Related]
19. SAR131675, a VEGRF3 Inhibitor, Modulates the Immune Response and Reduces the Growth of Colorectal Cancer Liver Metastasis.
Walsh KA; Kastrappis G; Fifis T; Paolini R; Christophi C; Perini MV
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681695
[TBL] [Abstract][Full Text] [Related]
20. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.
Sudhesh Dev S; Zainal Abidin SA; Farghadani R; Othman I; Naidu R
Front Pharmacol; 2021; 12():772510. PubMed ID: 34867402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
